IL-23p19 Antagonists vs. Ustekinumab for Treatment of Crohn’s Disease: A Meta-analysis of Randomized Controlled Trials
Related Posts
Zhang L, Chen D, Long Y, Li L, Lyu Y, Meng M, Ma Y, Wu Y, Leung FW, Sha W, Chen H, Liu Y. The[...]
Silvey S, Patel N, O'Leary JG, Jakab SS, Patton H, Rogal S, Markley JD, Cheung R, Patel A, Morgan TR, Bajaj JS. Secondary SBP Prophylaxis[...]
Larauche M, Mahurkar-Joshi S, Biraud M, Ju T, Mayer EA, Chang L. Sex-dependent alterations of colonic epithelial permeability: relevance to irritable bowel syndrome. Front Physiol.[...]